GlassScriptPhysician profile
Jean Hertel
NPI 1952367682
$903.23
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $761 · 2020: $142.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $199.75 | 2019-2020 | |
| Zyla Life Sciences, INC. | $178.29 | 2019-2020 | |
| Misonix INC | $148.69 | 2019-2020 | |
| Melinta Therapeutics, LLC | $80.48 | 2019 | |
| Stryker Corporation | $71.78 | 2019 | |
| Bioventus LLC | $61.08 | 2019-2020 | |
| Smith+Nephew, INC. | $37.57 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $30.71 | 2019 | |
| Wright Medical Technology, INC. | $25.72 | 2019 | |
| Nabriva Therapeutics, Plc | $23.14 | 2020 | |
| Allergan, INC. | $20.41 | 2019 | |
| Orthofix Medical, INC. | $14.62 | 2019 | |
| Tactile Systems Technology INC | $10.99 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jean Hertel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.